Source news

zacks News

20 stories
zacks

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation?

Harmony Biosciences Holdings, Inc. HRMY sits at an interesting point for investors. The stock looks inexpensive by several valuation measures, but the company depends heavily on Wakix for revenues.That creates a balanced buy debate. HRMY has a profitable commercial franchise and a funded pipeline…

Zacks en
StocksUS
zacks

HRMY Growth Trends Beyond Wakix Could Shape Its Next Growth Phase

Harmony Biosciences Holdings, Inc. HRMY is no longer only a Wakix revenue story. The company is using its sleep-wake franchise to fund a broader neuroscience strategy.The central question is whether those emerging growth trends can turn pipeline investment into a more diversified business before co…

Zacks en
StocksUS
zacks

Harmony Biosciences Stock Outlook as Wakix Growth Meets Pipeline

Harmony Biosciences Holdings, Inc. HRMY is trying to turn a successful narcolepsy franchise into a broader neuroscience platform.The transition is funded by Wakix, which still does most of the commercial work. The question for investors is whether that cash-generating base can keep expanding while…

Zacks en
StocksUS
zacks

INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura

Shares of Incyte INCY hit a 52-week high of $115.56 on June 26. The stock has performed impressively over the past month, recording a gain of 19% compared with the industry’s growth of 7.5%.The stock has also outperformed the medical sector and the S&P 500 Index during this timeframe.INCY Outperfor…

Zacks en
zacks

Real Estate ETF (AVRE) Touches a New 52-Week High

For investors seeking momentum, Avantis Real Estate ETF AVRE is probably on the radar now. The fund just hit a 52-week high and jumped 12.7% from its 52-week low price of $42.98 per share.But are there more gains in store for this ETF? Let’s take a quick look at the fund and its near-term outlook t…

Zacks en
ETFs
zacks

Can Duke Energy's Investment Plan Deliver Years of Earnings Growth?

Duke Energy DUK is entering one of the largest capital investment cycles in its history, positioning itself to benefit from rising electricity demand while maintaining relatively predictable cash flows.Duke Energy plans to invest approximately $103 billion between 2026 and 2030 to modernize its reg…

Zacks en
StocksUS
zacks

Can Encompass Health's Expansion Strategy Drive Its Next Growth Phase?

Encompass Health Corporation EHC has reached an interesting point in its growth story. Demand is no longer the primary metric to watch. Supported by an aging U.S. population, the need for inpatient rehabilitation services continues to grow. Now the key question hinges on scale: Can EHC expand capac…

Zacks en
StocksUS

GMED vs. MDT: Which Medical Stock Has More Upside Potential?

Over the past year, shares of Globus Medical GMED and Medtronic MDT have gained 46.1% and 7.6%, respectively, significantly outperforming the industry’s 9.6% decline. U.S. medical stocks offer strong structural growth prospects driven by an aging global population, rising chronic disease prevalence…

Zacks en
StocksUS
zacks

Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?

Intuitive Surgical’s ISRG long-term competitive advantage increasingly rests on its “Quintuple Aim” strategy, a framework centered on delivering better clinical outcomes, improved patient experience, enhanced care team efficiency, lower total cost of care, and broader access to treatment.Management…

Zacks en
StocksUS
zacks

Can Carter's Brand Strength and Omnichannel Strategy Sustain Growth?

Carter's, Inc. CRI continues to leverage its well-established brands to drive customer demand. The company is investing in product innovation, expanding assortments and introducing trend-right designs to keep its brands relevant. Its strong brand equity enables it to attract both value-conscious an…

Zacks en
StocksUS
zacks

Why HF Sinclair Is a Cash Flow Story, Not Merely a Valuation Play

HF Sinclair Corporation’s DINO investment appeal leans primarily on its ability to turn refining strength into cash while trading at a discounted valuation.The stock trades at a cheaper forward sales multiple, but the investment question is not valuation alone. It is whether stronger regional fuel…

Zacks en
StocksUS
zacks

Cameco's Adjusted EBITDA Up 44% in Q126: More Upside Ahead?

Cameco Corporation’s CCJ adjusted EBITDA has shown a strong and sustained upward trajectory over the past few years, driven primarily by uranium price strength and contributions from Westinghouse.In the first quarter of 2026, adjusted EBITDA rose 44% year over year to CAD 509 million ($372 million…

Zacks en
FuturesStocksCA
zacks

HF Sinclair's Multiple Growth Levers Strengthen Its Investment Case

HF Sinclair Corporation DINO benefits from several downstream trends shaping energy markets in 2026: tighter regional fuel supplies, resilient distillate demand, improving renewable diesel economics and a growing need for operational flexibility.Rather than relying on a single refining cycle, the c…

Zacks en
StocksUS
zacks

Here's Why You Should Retain Powell Industries in Your Portfolio

Powell Industries, Inc.’s POWL robust momentum can be largely attributed to its strong foothold and strength in several key markets, including oil and gas, electric utility, and commercial & other industrial. The company’s results for the second quarter of fiscal 2026 (ended March 2026) indicated s…

Zacks en
StocksUS
zacks

Is Holding Regency Centers Stock Still Smart Move for Your Portfolio?

Regency Centers REG owns grocery-anchored shopping centers in affluent suburban markets, supporting steady customer traffic, leasing demand and rental growth. Strong leasing activity, healthy rent spreads and an active development pipeline are expected to support future earnings.The company continu…

Zacks en
StocksUS
zacks

MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines

Shares of Moderna MRNA rose nearly 13% on Friday after the company unveiled a long-term strategy to transform itself from a vaccine-maker into a diversified biotechnology company.Moderna Looks Beyond Its Vaccine BusinessAt its Science Day event, Moderna outlined plans to expand beyond its tradition…

Zacks en
StocksUS